{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T04:11:27Z","timestamp":1751515887578,"version":"3.41.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018936","name":"Universit\u00e4tsklinikum Heidelberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018936","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Medical care can fail for various reasons: diseases can remain undetected and their severity misjudged, therapies can be incorrectly dosed or ineffective, and therapies can trigger new conditions or adverse drug reactions (ADR). To manage the complexity of changing patient circumstances, data-driven techniques play an increasingly important role in monitoring patient safety and treatment success. Therefore, clinical prediction models need to consider longitudinal factors (\u201cPrescribing Monitoring\u201d) to ensure clinically meaningful results and avoid misclassification in the dynamic health situation of the individual patient.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We have conducted a scoping review (OSF registration: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"10.17605\/OSF.IO\/P93TZ\" ext-link-type=\"doi\">https:\/\/doi.org\/10.17605\/OSF.IO\/P93TZ<\/jats:ext-link>) on prediction models for ADR to collect potential use cases for Prescribing Monitoring. This review identified 2435 relevant studies in English that were published in MEDLINE or EMBASE. Two reviewers screened the records for inclusion, with a third reviewer making the final decision in the event of discrepancies. In order to derive recommendations on the way towards a Prescribing Monitoring system, the following elements were extracted and interpreted: the prediction models used, selection of candidate predictors, use of longitudinal factors, and model performance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 56 studies were included after the screening process. We identified the main areas of current research in ADR prediction, all covering clinically important outcomes. We identified Prescribing Monitoring use cases based on their potential to (i) make individual predictions considering specific patient characteristics, (ii) make longitudinal predictions in a near time frame, and (iii) make dynamic predictions by updating predictions with previous risk predictions and newly available data. As a further aside, we use hyperkalaemia as an example to discuss the framework for developing Prescribing Monitoring in an electronic health record (EHR).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This scoping review provides an overview of the use of time-varying effects and longitudinal variables in current prediction model research. For application to clinical cases, prediction models should be developed, validated and implemented on this basis, so that time-dependent information can enable continuous monitoring of individual patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12911-025-03096-3","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T16:16:02Z","timestamp":1751472962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Towards a prescribing monitoring system for medication safety evaluation within electronic health records: a scoping review"],"prefix":"10.1186","volume":"25","author":[{"given":"Camilo","family":"Scherkl","sequence":"first","affiliation":[]},{"given":"Theresa","family":"Dierkes","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Metzner","sequence":"additional","affiliation":[]},{"given":"David","family":"Czock","sequence":"additional","affiliation":[]},{"given":"Hanna M.","family":"Seidling","sequence":"additional","affiliation":[]},{"given":"Walter E.","family":"Haefeli","sequence":"additional","affiliation":[]},{"given":"Andreas D.","family":"Meid","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"3096_CR1","doi-asserted-by":"publisher","first-page":"e15063","DOI":"10.7759\/cureus.15063","volume":"13","author":"SC Shapiro","year":"2021","unstructured":"Shapiro SC. Biomarkers in rheumatoid arthritis. Cureus. 2021;13:e15063. https:\/\/doi.org\/10.7759\/cureus.15063.","journal-title":"Cureus"},{"key":"3096_CR2","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","volume":"46","author":"MH Abdul-Aziz","year":"2020","unstructured":"Abdul-Aziz MH, Alffenaar J-WC, Bassetti M, Bracht H, Dimopoulos G, Marriott D, et al. Antimicrobial therapeutic drug monitoring in critically ill adult patients: a position paper. Intensive Care Med. 2020;46:1127\u201353. https:\/\/doi.org\/10.1007\/s00134-020-06050-1.","journal-title":"Intensive Care Med"},{"key":"3096_CR3","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1111\/bcp.15580","volume":"89","author":"KM Muylle","year":"2023","unstructured":"Muylle KM, van Laere S, Pannone L, Coenen S, de Asmundis C, Dupont AG, Cornu P. Added value of patient- and drug-related factors to stratify drug-drug interaction alerts for risk of QT prolongation: development and validation of a risk prediction model. Br J Clin Pharmacol. 2023;89:1374\u201385. https:\/\/doi.org\/10.1111\/bcp.15580.","journal-title":"Br J Clin Pharmacol"},{"key":"3096_CR4","doi-asserted-by":"publisher","first-page":"m1501","DOI":"10.1136\/bmj.m1501","volume":"369","author":"S Gerry","year":"2020","unstructured":"Gerry S, Bonnici T, Birks J, Kirtley S, Virdee PS, Watkinson PJ, Collins GS. Early warning scores for detecting deterioration in adult hospital patients: systematic review and critical appraisal of methodology. BMJ. 2020;369:m1501. https:\/\/doi.org\/10.1136\/bmj.m1501.","journal-title":"BMJ"},{"key":"3096_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12883-019-1377-4","volume":"19","author":"N Wang","year":"2019","unstructured":"Wang N, Chen J, Xiao H, Wu L, Jiang H, Zhou Y. Application of artificial neural network model in diagnosis of alzheimer\u2019s disease. BMC Neurol. 2019;19:154. https:\/\/doi.org\/10.1186\/s12883-019-1377-4.","journal-title":"BMC Neurol"},{"key":"3096_CR6","doi-asserted-by":"publisher","first-page":"e044779","DOI":"10.1136\/bmjopen-2020-044779","volume":"11","author":"F Li","year":"2021","unstructured":"Li F, Xin H, Zhang J, Fu M, Zhou J, Lian Z. Prediction model of in-hospital mortality in intensive care unit patients with heart failure: machine learning-based, retrospective analysis of the MIMIC-III database. BMJ Open. 2021;11:e044779. https:\/\/doi.org\/10.1136\/bmjopen-2020-044779.","journal-title":"BMJ Open"},{"key":"3096_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2150","author":"SM Sutherland","year":"2018","unstructured":"Sutherland SM. Pharmacotherapy. 2018;38:804\u201312. https:\/\/doi.org\/10.1002\/phar.2150. Electronic Health Record-Enabled Big-Data Approaches to Nephrotoxin-Associated Acute Kidney Injury Risk Prediction."},{"key":"3096_CR8","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1007\/s11096-022-01468-7","volume":"44","author":"Q Hu","year":"2022","unstructured":"Hu Q, Wu B, Wu J, Xu T. Predicting adverse drug events in older inpatients: a machine learning study. Int J Clin Pharm. 2022;44:1304\u201311. https:\/\/doi.org\/10.1007\/s11096-022-01468-7.","journal-title":"Int J Clin Pharm"},{"key":"3096_CR9","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1111\/bjh.18737","volume":"201","author":"D Mora","year":"2023","unstructured":"Mora D, Mateo J, Nieto JA, Bikdeli B, Yamashita Y, Barco S, et al. Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations. Br J Haematol. 2023;201:971\u201381. https:\/\/doi.org\/10.1111\/bjh.18737.","journal-title":"Br J Haematol"},{"key":"3096_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/s20226460","author":"D-Y Kim","year":"2020","unstructured":"Kim D-Y, Choi D-S, Kim J, Chun SW, Gil H-W, Cho N-J, et al. Developing an individual glucose prediction model using recurrent neural network. Sens (Basel). 2020. https:\/\/doi.org\/10.3390\/s20226460.","journal-title":"Sens (Basel)"},{"key":"3096_CR11","doi-asserted-by":"publisher","first-page":"103580","DOI":"10.1016\/j.compbiomed.2019.103580","volume":"116","author":"RJ Kate","year":"2020","unstructured":"Kate RJ, Pearce N, Mazumdar D, Nilakantan V. A continual prediction model for inpatient acute kidney injury. Comput Biol Med. 2020;116:103580. https:\/\/doi.org\/10.1016\/j.compbiomed.2019.103580.","journal-title":"Comput Biol Med"},{"key":"3096_CR12","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/bimj.201900112","volume":"62","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Huang X, Li L. Dynamic prediction of time to a clinical event with sparse and irregularly measured longitudinal biomarkers. Biom J. 2020;62:1371\u201393. https:\/\/doi.org\/10.1002\/bimj.201900112.","journal-title":"Biom J"},{"key":"3096_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/XEB.0000000000000050","volume":"13","author":"MDJ Peters","year":"2015","unstructured":"Peters MDJ, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 2015;13:141\u20136. https:\/\/doi.org\/10.1097\/XEB.0000000000000050.","journal-title":"Int J Evid Based Healthc"},{"key":"3096_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169:467\u201373. https:\/\/doi.org\/10.7326\/M18-0850.","journal-title":"Ann Intern Med"},{"key":"3096_CR15","unstructured":"Camilo Scherkl T, Dierkes D, Czock M, Metzner HM, Seidling W-E, Haefeli, Andreas D. Meid. Prediction of (adverse) drug effects in clinical decision support systems for longitudinal prescribing monitoring: a scoping review protocol. Open Science Framework. 2023."},{"key":"3096_CR16","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/jamia\/ocad014","volume":"30","author":"IAR Yasrebi-de Kom","year":"2023","unstructured":"Yasrebi-de Kom IAR, Dongelmans DA, de Keizer NF, Jager KJ, Schut MC, Abu-Hanna A, Klopotowska JE. Electronic health record-based prediction models for in-hospital adverse drug event diagnosis or prognosis: a systematic review. J Am Med Inf Assoc. 2023;30:978\u201388. https:\/\/doi.org\/10.1093\/jamia\/ocad014.","journal-title":"J Am Med Inf Assoc"},{"key":"3096_CR17","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/bcp.13514","volume":"84","author":"N Falconer","year":"2018","unstructured":"Falconer N, Barras M, Cottrell N. Systematic review of predictive risk models for adverse drug events in hospitalized patients. Br J Clin Pharmacol. 2018;84:846\u201364. https:\/\/doi.org\/10.1111\/bcp.13514.","journal-title":"Br J Clin Pharmacol"},{"key":"3096_CR18","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1016\/S2589-7500(21)00229-6","volume":"4","author":"A Syrowatka","year":"2022","unstructured":"Syrowatka A, Song W, Amato MG, Foer D, Edrees H, Co Z, et al. Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review. Lancet Digit Health. 2022;4:e137\u201348. https:\/\/doi.org\/10.1016\/S2589-7500(21)00229-6.","journal-title":"Lancet Digit Health"},{"key":"3096_CR19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5:210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4.","journal-title":"Syst Rev"},{"key":"3096_CR20","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.2146\/ajhp160995","volume":"74","author":"AG Winterstein","year":"2017","unstructured":"Winterstein AG, Staley B, Henriksen C, Xu D, Lipori G, Jeon N, et al. Development and validation of a complexity score to rank hospitalized patients at risk for preventable adverse drug events. Am J Health Syst Pharm. 2017;74:1970\u201384. https:\/\/doi.org\/10.2146\/ajhp160995.","journal-title":"Am J Health Syst Pharm"},{"key":"3096_CR21","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1097\/CCM.0000000000003123","volume":"46","author":"JL Koyner","year":"2018","unstructured":"Koyner JL, Carey KA, Edelson DP, Churpek MM. The development of a machine learning inpatient acute kidney injury prediction model. Crit Care Med. 2018;46:1070\u20137. https:\/\/doi.org\/10.1097\/CCM.0000000000003123.","journal-title":"Crit Care Med"},{"key":"3096_CR22","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.2146\/ajhp180013","volume":"75","author":"Y Choi","year":"2018","unstructured":"Choi Y, Staley B, Henriksen C, Xu D, Lipori G, Brumback B, Winterstein AG. A dynamic risk model for inpatient falls. Am J Health Syst Pharm. 2018;75:1293\u2013303. https:\/\/doi.org\/10.2146\/ajhp180013.","journal-title":"Am J Health Syst Pharm"},{"key":"3096_CR23","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.2146\/ajhp180071","volume":"75","author":"AG Winterstein","year":"2018","unstructured":"Winterstein AG, Jeon N, Staley B, Xu D, Henriksen C, Lipori GP. Development and validation of an automated algorithm for identifying patients at high risk for drug-induced hypoglycemia. Am J Health Syst Pharm. 2018;75:1714\u201328. https:\/\/doi.org\/10.2146\/ajhp180071.","journal-title":"Am J Health Syst Pharm"},{"key":"3096_CR24","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1093\/ajhp\/zxz043","volume":"76","author":"N Jeon","year":"2019","unstructured":"Jeon N, Staley B, Henriksen C, Lipori GP, Winterstein AG. Development and validation of an automated algorithm for identifying patients at higher risk for drug-induced acute kidney injury. Am J Health Syst Pharm. 2019;76:654\u201366. https:\/\/doi.org\/10.1093\/ajhp\/zxz043.","journal-title":"Am J Health Syst Pharm"},{"key":"3096_CR25","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1111\/bcp.14560","volume":"87","author":"N Falconer","year":"2021","unstructured":"Falconer N, Barras M, Abdel-Hafez A, Radburn S, Cottrell N. Development and validation of the adverse inpatient medication event model (AIME). Br J Clin Pharmacol. 2021;87:1512\u201324. https:\/\/doi.org\/10.1111\/bcp.14560.","journal-title":"Br J Clin Pharmacol"},{"key":"3096_CR26","doi-asserted-by":"publisher","first-page":"e2030913","DOI":"10.1001\/jamanetworkopen.2020.30913","volume":"4","author":"NN Mathioudakis","year":"2021","unstructured":"Mathioudakis NN, Abusamaan MS, Shakarchi AF, Sokolinsky S, Fayzullin S, McGready J, et al. Development and validation of a machine learning model to predict Near-Term risk of iatrogenic hypoglycemia in hospitalized patients. JAMA Netw Open. 2021;4:e2030913. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.30913.","journal-title":"JAMA Netw Open"},{"key":"3096_CR27","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1007\/s11096-023-01566-0","volume":"45","author":"AE Schulthess-Lisibach","year":"2023","unstructured":"Schulthess-Lisibach AE, Gallucci G, Benelli V, K\u00e4lin R, Schulthess S, Cattaneo M, et al. Predicting delirium in older non-intensive care unit inpatients: development and validation of the delirium risk tool (DELIKT). Int J Clin Pharm. 2023;45:1118\u201327. https:\/\/doi.org\/10.1007\/s11096-023-01566-0.","journal-title":"Int J Clin Pharm"},{"key":"3096_CR28","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1111\/cas.16352","volume":"115","author":"S-Y Zhu","year":"2024","unstructured":"Zhu S-Y, Yang T-T, Zhao Y-Z, Sun Y, Zheng X-M, Xu H-B. Interpretable machine learning model predicting immune checkpoint inhibitor-induced hypothyroidism: A retrospective cohort study. Cancer Sci. 2024;115:3767\u201375. https:\/\/doi.org\/10.1111\/cas.16352.","journal-title":"Cancer Sci"},{"key":"3096_CR29","doi-asserted-by":"publisher","first-page":"23443","DOI":"10.1038\/s41598-024-74366-9","volume":"14","author":"Y Kim","year":"2024","unstructured":"Kim Y, Kang H, Seo H, Choi H, Kim M, Han J, et al. Development and transfer learning of self-attention model for major adverse cardiovascular events prediction across hospitals. Sci Rep. 2024;14:23443. https:\/\/doi.org\/10.1038\/s41598-024-74366-9.","journal-title":"Sci Rep"},{"key":"3096_CR30","doi-asserted-by":"publisher","first-page":"107327482412907","DOI":"10.1177\/10732748241290767","volume":"31","author":"Y Sisi","year":"2024","unstructured":"Sisi Y, Genpeng L, Yao C, Suting S, Rongying T, Du Jiayi, et al. A nomogram for predicting Cancer-Associated venous thromboembolism in hospitalized patients receiving chemoradiotherapy for Cancer. Cancer Control. 2024;31:10732748241290767. https:\/\/doi.org\/10.1177\/10732748241290767.","journal-title":"Cancer Control"},{"key":"3096_CR31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.joms.2024.11.013","volume":"83","author":"K Warin","year":"2025","unstructured":"Warin K, Lochanachit S, Pavarangkoon P, Techapanurak E, Somyanonthanakul R. Prediction of Medication-Related osteonecrosis of the jaw in patients receiving antiresorptive therapy using machine learning models. J Oral Maxillofac Surg. 2025;83:353\u201365. https:\/\/doi.org\/10.1016\/j.joms.2024.11.013.","journal-title":"J Oral Maxillofac Surg"},{"key":"3096_CR32","doi-asserted-by":"publisher","first-page":"e70115","DOI":"10.1111\/cts.70115","volume":"18","author":"K Ambe","year":"2025","unstructured":"Ambe K, Aoki Y, Murashima M, Wachino C, Deki Y, Ieda M, et al. Prediction of Cisplatin-Induced acute kidney injury using an interpretable machine learning model and electronic medical record information. Clin Transl Sci. 2025;18:e70115. https:\/\/doi.org\/10.1111\/cts.70115.","journal-title":"Clin Transl Sci"},{"key":"3096_CR33","doi-asserted-by":"publisher","first-page":"e000499","DOI":"10.1136\/bmjdrc-2017-000499","volume":"6","author":"NN Mathioudakis","year":"2018","unstructured":"Mathioudakis NN, Everett E, Routh S, Pronovost PJ, Yeh H-C, Golden SH, Saria S. Development and validation of a prediction model for insulin-associated hypoglycemia in non-critically ill hospitalized adults. BMJ Open Diabetes Res Care. 2018;6:e000499. https:\/\/doi.org\/10.1136\/bmjdrc-2017-000499.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"3096_CR34","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/ajhp\/zxz100","volume":"76","author":"JM Hincapie-Castillo","year":"2019","unstructured":"Hincapie-Castillo JM, Staley B, Henriksen C, Saidi A, Lipori GP, Winterstein AG. Development of a predictive model for drug-associated QT prolongation in the inpatient setting using electronic health record data. Am J Health Syst Pharm. 2019;76:1059\u201370. https:\/\/doi.org\/10.1093\/ajhp\/zxz100.","journal-title":"Am J Health Syst Pharm"},{"key":"3096_CR35","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/1074248421995348","volume":"26","author":"ST Simon","year":"2021","unstructured":"Simon ST, Mandair D, Tiwari P, Rosenberg MA. Prediction of Drug-Induced long QT syndrome using machine learning applied to harmonized electronic health record data. J Cardiovasc Pharmacol Ther. 2021;26:335\u201340. https:\/\/doi.org\/10.1177\/1074248421995348.","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"3096_CR36","doi-asserted-by":"publisher","first-page":"e42163","DOI":"10.2196\/42163","volume":"24","author":"ST Simon","year":"2022","unstructured":"Simon ST, Trinkley KE, Malone DC, Rosenberg MA. Interpretable machine learning prediction of Drug-Induced QT prolongation: electronic health record analysis. J Med Internet Res. 2022;24:e42163. https:\/\/doi.org\/10.2196\/42163.","journal-title":"J Med Internet Res"},{"key":"3096_CR37","doi-asserted-by":"publisher","first-page":"1027230","DOI":"10.3389\/fphar.2022.1027230","volume":"13","author":"F Mu","year":"2022","unstructured":"Mu F, Cui C, Tang M, Guo G, Zhang H, Ge J, et al. Analysis of a machine learning-based risk stratification scheme for acute kidney injury in Vancomycin. Front Pharmacol. 2022;13:1027230. https:\/\/doi.org\/10.3389\/fphar.2022.1027230.","journal-title":"Front Pharmacol"},{"key":"3096_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12123157","author":"X Yu","year":"2022","unstructured":"Yu X, Wu R, Ji Y, Huang M, Feng Z. Identifying patients at risk of acute kidney injury among patients receiving immune checkpoint inhibitors: A machine learning approach. Diagnostics (Basel). 2022. https:\/\/doi.org\/10.3390\/diagnostics12123157.","journal-title":"Diagnostics (Basel)"},{"key":"3096_CR39","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1177\/19322968221119788","volume":"18","author":"AP Wright","year":"2024","unstructured":"Wright AP, Embi PJ, Nelson SD, Smith JC, Turchin A, Mize DE. Development and validation of inpatient hypoglycemia models centered around the insulin ordering process. J Diabetes Sci Technol. 2024;18:423\u20139. https:\/\/doi.org\/10.1177\/19322968221119788.","journal-title":"J Diabetes Sci Technol"},{"key":"3096_CR40","doi-asserted-by":"publisher","first-page":"108611","DOI":"10.1016\/j.diabres.2020.108611","volume":"171","author":"M Elbaz","year":"2021","unstructured":"Elbaz M, Nashashibi J, Kushnir S, Leibovici L. Predicting hypoglycemia in hospitalized patients with diabetes: A derivation and validation study. Diabetes Res Clin Pract. 2021;171:108611. https:\/\/doi.org\/10.1016\/j.diabres.2020.108611.","journal-title":"Diabetes Res Clin Pract"},{"key":"3096_CR41","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1111\/dme.13409","volume":"34","author":"K Stuart","year":"2017","unstructured":"Stuart K, Adderley NJ, Marshall T, Rayman G, Sitch A, Manley S, et al. Predicting inpatient hypoglycaemia in hospitalized patients with diabetes: a retrospective analysis of 9584 admissions with diabetes. Diabet Med. 2017;34:1385\u201391. https:\/\/doi.org\/10.1111\/dme.13409.","journal-title":"Diabet Med"},{"key":"3096_CR42","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/bjh.15161","volume":"181","author":"AR Dreijer","year":"2018","unstructured":"Dreijer AR, Biedermann JS, Diepstraten J, Lindemans AD, Kruip MJHA, van den Bemt PMLA, Vergouwe Y. Development of a clinical prediction model for an international normalised ratio\u2009\u2265\u20094\u00b75 in hospitalised patients using vitamin K antagonists. Br J Haematol. 2018;181:102\u201310. https:\/\/doi.org\/10.1111\/bjh.15161.","journal-title":"Br J Haematol"},{"key":"3096_CR43","doi-asserted-by":"publisher","first-page":"1158421","DOI":"10.3389\/fphar.2023.1158421","volume":"14","author":"Y Hua","year":"2023","unstructured":"Hua Y, Zou Y, Guan M, Yuan H-Y, Zhou Y, Liu F. Predictive model of chemotherapy-related toxicity in elderly Chinese cancer patients. Front Pharmacol. 2023;14:1158421. https:\/\/doi.org\/10.3389\/fphar.2023.1158421.","journal-title":"Front Pharmacol"},{"key":"3096_CR44","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1111\/bcp.15846","volume":"89","author":"B Langenberger","year":"2023","unstructured":"Langenberger B. Machine learning as a tool to identify inpatients who are not at risk of adverse drug events in a large dataset of a tertiary care hospital in the USA. Br J Clin Pharmacol. 2023;89:3523\u201338. https:\/\/doi.org\/10.1111\/bcp.15846.","journal-title":"Br J Clin Pharmacol"},{"key":"3096_CR45","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s40001-023-01306-0","volume":"28","author":"C Guan","year":"2023","unstructured":"Guan C, Li C, Xu L, Che L, Wang Y, Yang C, et al. Hospitalized patients received Furosemide undergoing acute kidney injury: the risk and prediction tool. Eur J Med Res. 2023;28:312. https:\/\/doi.org\/10.1186\/s40001-023-01306-0.","journal-title":"Eur J Med Res"},{"key":"3096_CR46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40360-024-00761-7","volume":"25","author":"F an Fu, Ge","year":"2024","unstructured":"an Fu, Ge F, Wang Y, Guo H, Zhu M, Li S, et al. Development and internal validation of a model for predicting cefoperazone\/sulbactam-associated coagulation disorders in Chinese inpatients. BMC Pharmacol Toxicol. 2024;25:41. https:\/\/doi.org\/10.1186\/s40360-024-00761-7.","journal-title":"BMC Pharmacol Toxicol"},{"key":"3096_CR47","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12911-024-02694-x","volume":"24","author":"J Zhu","year":"2024","unstructured":"Zhu J, Zhao R, Yu Z, Li L, Wei J, Guan Y. Machine learning-based prediction model for hypofibrinogenemia after Tigecycline therapy. BMC Med Inf Decis Mak. 2024;24:284. https:\/\/doi.org\/10.1186\/s12911-024-02694-x.","journal-title":"BMC Med Inf Decis Mak"},{"key":"3096_CR48","doi-asserted-by":"publisher","first-page":"815188","DOI":"10.3389\/fphar.2022.815188","volume":"13","author":"JY Kim","year":"2022","unstructured":"Kim JY, Kim KY, Yee J, Gwak HS. Risk scoring system for Vancomycin-Associated acute kidney injury. Front Pharmacol. 2022;13:815188. https:\/\/doi.org\/10.3389\/fphar.2022.815188.","journal-title":"Front Pharmacol"},{"key":"3096_CR49","doi-asserted-by":"publisher","first-page":"100918","DOI":"10.1016\/j.xkme.2024.100918","volume":"6","author":"BR Griffin","year":"2024","unstructured":"Griffin BR, Mudireddy A, Horne BD, Chonchol M, Goldstein SL, Goto M, et al. Predicting nephrotoxic acute kidney injury in hospitalized adults: A machine learning algorithm. Kidney Med. 2024;6:100918. https:\/\/doi.org\/10.1016\/j.xkme.2024.100918.","journal-title":"Kidney Med"},{"key":"3096_CR50","doi-asserted-by":"publisher","first-page":"102066","DOI":"10.1016\/j.ejon.2021.102066","volume":"56","author":"J On","year":"2022","unstructured":"On J, Park H-A, Yoo S. Development of a prediction models for chemotherapy-induced adverse drug reactions: A retrospective observational study using electronic health records. Eur J Oncol Nurs. 2022;56:102066. https:\/\/doi.org\/10.1016\/j.ejon.2021.102066.","journal-title":"Eur J Oncol Nurs"},{"key":"3096_CR51","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.2337\/dc19-1743","volume":"43","author":"Y Ruan","year":"2020","unstructured":"Ruan Y, Bellot A, Moysova Z, Tan GD, Lumb A, Davies J, et al. Predicting the risk of inpatient hypoglycemia with machine learning using electronic health records. Diabetes Care. 2020;43:1504\u201311. https:\/\/doi.org\/10.2337\/dc19-1743.","journal-title":"Diabetes Care"},{"key":"3096_CR52","doi-asserted-by":"publisher","first-page":"e0236789","DOI":"10.1371\/journal.pone.0236789","volume":"15","author":"S Imai","year":"2020","unstructured":"Imai S, Takekuma Y, Kashiwagi H, Miyai T, Kobayashi M, Iseki K, Sugawara M. Validation of the usefulness of artificial neural networks for risk prediction of adverse drug reactions used for individual patients in clinical practice. PLoS ONE. 2020;15:e0236789. https:\/\/doi.org\/10.1371\/journal.pone.0236789.","journal-title":"PLoS ONE"},{"key":"3096_CR53","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/jep.13039","volume":"25","author":"S Imai","year":"2019","unstructured":"Imai S, Yamada T, Kasashi K, Niinuma Y, Kobayashi M, Iseki K. Construction of a risk prediction model of vancomycin-associated nephrotoxicity to be used at the time of initial therapeutic drug monitoring: A data mining analysis using a decision tree model. J Eval Clin Pract. 2019;25:163\u201370. https:\/\/doi.org\/10.1111\/jep.13039.","journal-title":"J Eval Clin Pract"},{"key":"3096_CR54","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1248\/bpb.b24-00506","volume":"47","author":"S Mizuno","year":"2024","unstructured":"Mizuno S, Noda T, Mogushi K, Hase T, Iida Y, Takeuchi K, et al. Prediction of Vancomycin-Associated nephrotoxicity based on the area under the Concentration-Time curve of vancomycin: A machine learning analysis. Biol Pharm Bull. 2024;47:1946\u201352. https:\/\/doi.org\/10.1248\/bpb.b24-00506.","journal-title":"Biol Pharm Bull"},{"key":"3096_CR55","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/jamia\/ocw050","volume":"24","author":"E Eschmann","year":"2017","unstructured":"Eschmann E, Beeler PE, Schneemann M, Blaser J. Developing strategies for predicting hyperkalemia in potassium-increasing drug-drug interactions. J Am Med Inf Assoc. 2017;24:60\u20136. https:\/\/doi.org\/10.1093\/jamia\/ocw050.","journal-title":"J Am Med Inf Assoc"},{"key":"3096_CR56","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41586-019-1390-1","volume":"572","author":"N Toma\u0161ev","year":"2019","unstructured":"Toma\u0161ev N, Glorot X, Rae JW, Zielinski M, Askham H, Saraiva A, et al. A clinically applicable approach to continuous prediction of future acute kidney injury. Nature. 2019;572:116\u20139. https:\/\/doi.org\/10.1038\/s41586-019-1390-1.","journal-title":"Nature"},{"key":"3096_CR57","doi-asserted-by":"publisher","first-page":"462","DOI":"10.12788\/jhm.3196","volume":"14","author":"KE Yonekawa","year":"2019","unstructured":"Yonekawa KE, Zhou C, Haaland WL, Wright DR. Nephrotoxin-Related acute kidney injury and predicting High-Risk medication combinations in the hospitalized child. J Hosp Med. 2019;14:462\u20137. https:\/\/doi.org\/10.12788\/jhm.3196.","journal-title":"J Hosp Med"},{"key":"3096_CR58","doi-asserted-by":"publisher","first-page":"657853","DOI":"10.3389\/fphar.2021.657853","volume":"12","author":"C Yu","year":"2021","unstructured":"Yu C, Guo D, Yao C, Zhu Y, Liu S, Kong X. Development and validation of a nomogram for predicting Drug-Induced acute kidney injury in hospitalized patients: A Case-Control study based on Propensity-Score matching. Front Pharmacol. 2021;12:657853. https:\/\/doi.org\/10.3389\/fphar.2021.657853.","journal-title":"Front Pharmacol"},{"key":"3096_CR59","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12911-020-01181-3","volume":"20","author":"FA Berger","year":"2020","unstructured":"Berger FA, van der Sijs H, Becker ML, van Gelder T, van den Bemt PMLA. Development and validation of a tool to assess the risk of QT drug-drug interactions in clinical practice. BMC Med Inf Decis Mak. 2020;20:171. https:\/\/doi.org\/10.1186\/s12911-020-01181-3.","journal-title":"BMC Med Inf Decis Mak"},{"key":"3096_CR60","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1111\/jep.12767","volume":"23","author":"S Imai","year":"2017","unstructured":"Imai S, Yamada T, Kasashi K, Kobayashi M, Iseki K. Usefulness of a decision tree model for the analysis of adverse drug reactions: evaluation of a risk prediction model of vancomycin-associated nephrotoxicity constructed using a data mining procedure. J Eval Clin Pract. 2017;23:1240\u20136. https:\/\/doi.org\/10.1111\/jep.12767.","journal-title":"J Eval Clin Pract"},{"key":"3096_CR61","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/cts.12731","volume":"13","author":"C Pan","year":"2020","unstructured":"Pan C, Wen A, Li X, Li D, Zhang Y, Liao Y, et al. Development and validation of a risk prediction model of Vancomycin-Associated nephrotoxicity in elderly patients: A pilot study. Clin Transl Sci. 2020;13:491\u20137. https:\/\/doi.org\/10.1111\/cts.12731.","journal-title":"Clin Transl Sci"},{"key":"3096_CR62","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2022-003258","author":"Y Qin","year":"2022","unstructured":"Qin Y, Chen Z, Gao S, Shen Y, Ye Y. Development and validation of a risk prediction model for linezolid-induced thrombocytopenia in elderly patients. Eur J Hosp Pharm. 2022. https:\/\/doi.org\/10.1136\/ejhpharm-2022-003258.","journal-title":"Eur J Hosp Pharm"},{"key":"3096_CR63","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jiac.2022.05.004","volume":"28","author":"I Maray","year":"2022","unstructured":"Maray I, Rodr\u00edguez-Ferreras A, \u00c1lvarez-Asteinza C, Alaguero-Calero M, Valledor P, Fern\u00e1ndez J. Linezolid induced thrombocytopenia in critically ill patients: risk factors and development of a machine learning-based prediction model. J Infect Chemother. 2022;28:1249\u201354. https:\/\/doi.org\/10.1016\/j.jiac.2022.05.004.","journal-title":"J Infect Chemother"},{"key":"3096_CR64","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1038\/s41598-023-27824-9","volume":"13","author":"S Zhou","year":"2023","unstructured":"Zhou S, Song B, Li C, Tang W, Zhang X, Jin X, et al. The predictive model for risk of chemotherapy-induced thrombocytopenia based on antineoplastic drugs for solid tumors in Eastern China. Sci Rep. 2023;13:3185. https:\/\/doi.org\/10.1038\/s41598-023-27824-9.","journal-title":"Sci Rep"},{"key":"3096_CR65","doi-asserted-by":"publisher","first-page":"e0272786","DOI":"10.1371\/journal.pone.0272786","volume":"17","author":"PN Thi Thu","year":"2022","unstructured":"Thi Thu PN, Quynh MNT, Van HN, Thanh HN, Minh KP. A logistic regression model based on inpatient health records to predict drug-induced liver injury caused by ramipril-An angiotensin-converting enzyme inhibitor. PLoS ONE. 2022;17:e0272786. https:\/\/doi.org\/10.1371\/journal.pone.0272786.","journal-title":"PLoS ONE"},{"key":"3096_CR66","doi-asserted-by":"publisher","first-page":"1502050","DOI":"10.3389\/fendo.2024.1502050","volume":"15","author":"R Gao","year":"2024","unstructured":"Gao R, Li Y, Li A, Zhou P, Zong H, Li Y. Risk factor screening and prediction modeling of Gastrointestinal adverse reactions caused by GLP-1RAs. Front Endocrinol (Lausanne). 2024;15:1502050. https:\/\/doi.org\/10.3389\/fendo.2024.1502050.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3096_CR67","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1007\/s00277-024-05734-8","volume":"103","author":"F Ma","year":"2024","unstructured":"Ma F, Zeng Z, Chen J, Zhang J. A new score for predicting intracranial hemorrhage in patients using antiplatelet drugs. Ann Hematol. 2024;103:2511\u201321. https:\/\/doi.org\/10.1007\/s00277-024-05734-8.","journal-title":"Ann Hematol"},{"key":"3096_CR68","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1080\/00365521.2023.2220460","volume":"58","author":"H Cao","year":"2023","unstructured":"Cao H, Xu H, Zhu M, Chu X, Zhang Z, Dong Y. A nomogram for predicting major Gastrointestinal bleeding in patients treated with Rivaroxaban. Scand J Gastroenterol. 2023;58:1228\u201336. https:\/\/doi.org\/10.1080\/00365521.2023.2220460.","journal-title":"Scand J Gastroenterol"},{"key":"3096_CR69","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12028-022-01442-1","volume":"37","author":"NA Haddad","year":"2022","unstructured":"Haddad NA, Schreier DJ, Fugate JE, Gajic O, Hocker SE, Ice CJ, et al. Incidence and predictive factors associated with Beta-Lactam neurotoxicity in the critically ill: A retrospective cohort study. Neurocrit Care. 2022;37:73\u201380. https:\/\/doi.org\/10.1007\/s12028-022-01442-1.","journal-title":"Neurocrit Care"},{"key":"3096_CR70","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/jcpt.12852","volume":"44","author":"S Imai","year":"2019","unstructured":"Imai S, Yamada T, Kasashi K, Ishiguro N, Kobayashi M, Iseki K. Construction of a flow chart-like risk prediction model of ganciclovir-induced neutropaenia including severity grade: A data mining approach using decision tree. J Clin Pharm Ther. 2019;44:726\u201334. https:\/\/doi.org\/10.1111\/jcpt.12852.","journal-title":"J Clin Pharm Ther"},{"key":"3096_CR71","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000519333","volume":"107","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Guo D, Kong X, Liu S, Yu C. A Risk-Prediction nomogram for neutropenia or febrile neutropenia after Etoposide-Based chemotherapy in Cancer patients: A retrospective cohort study. Pharmacology. 2022;107:69\u201380. https:\/\/doi.org\/10.1159\/000519333.","journal-title":"Pharmacology"},{"key":"3096_CR72","doi-asserted-by":"publisher","first-page":"e064089","DOI":"10.1136\/bmjopen-2022-064089","volume":"12","author":"S Roy","year":"2022","unstructured":"Roy S, Bruehl S, Feng X, Shotwell MS, van de Ven T, Shaw AD, Kertai MD. Developing a risk stratification tool for predicting opioid-related respiratory depression after non-cardiac surgery: a retrospective study. BMJ Open. 2022;12:e064089. https:\/\/doi.org\/10.1136\/bmjopen-2022-064089.","journal-title":"BMJ Open"},{"key":"3096_CR73","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12885-025-13427-2","volume":"25","author":"Q Chen","year":"2025","unstructured":"Chen Q, Huang G, Xia Y, Zhao H, Zheng Y, Liao Y. Development of a risk prediction nomogram model of pyrotinib-induced severe diarrhea. BMC Cancer. 2025;25:59. https:\/\/doi.org\/10.1186\/s12885-025-13427-2.","journal-title":"BMC Cancer"},{"key":"3096_CR74","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s11606-019-05490-w","volume":"35","author":"SJ Herzig","year":"2020","unstructured":"Herzig SJ, Stefan MS, Pekow PS, Shieh M-S, Soares W, Raghunathan K, Lindenauer PK. Risk factors for severe Opioid-Related adverse events in a National cohort of medical hospitalizations. J Gen Intern Med. 2020;35:538\u201345. https:\/\/doi.org\/10.1007\/s11606-019-05490-w.","journal-title":"J Gen Intern Med"},{"key":"3096_CR75","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.2146\/ajhp160387","volume":"74","author":"N Jeon","year":"2017","unstructured":"Jeon N, Staley B, Johns T, Lipori GP, Brumback B, Segal R, Winterstein AG. Identifying and characterizing preventable adverse drug events for prioritizing pharmacist intervention in hospitals. Am J Health Syst Pharm. 2017;74:1774\u201383. https:\/\/doi.org\/10.2146\/ajhp160387.","journal-title":"Am J Health Syst Pharm"},{"key":"3096_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11154254","author":"A Haerdtlein","year":"2022","unstructured":"Haerdtlein A, Boehmer AM, Karsten Dafonte K, Rottenkolber M, Jaehde U, Dreischulte T. Prioritisation of adverse drug events leading to hospital admission and occurring during hospitalisation: A RAND survey. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11154254.","journal-title":"J Clin Med"},{"key":"3096_CR77","doi-asserted-by":"publisher","first-page":"e000262","DOI":"10.1136\/fmch-2019-000262","volume":"8","author":"MZI Chowdhury","year":"2020","unstructured":"Chowdhury MZI, Turin TC. Variable selection strategies and its importance in clinical prediction modelling. Fam Med Community Health. 2020;8:e000262. https:\/\/doi.org\/10.1136\/fmch-2019-000262.","journal-title":"Fam Med Community Health"},{"key":"3096_CR78","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jclinepi.2021.11.023","volume":"142","author":"S Nijman","year":"2022","unstructured":"Nijman S, Leeuwenberg AM, Beekers I, Verkouter I, Jacobs J, Bots ML, et al. Missing data is poorly handled and reported in prediction model studies using machine learning: a literature review. J Clin Epidemiol. 2022;142:218\u201329. https:\/\/doi.org\/10.1016\/j.jclinepi.2021.11.023.","journal-title":"J Clin Epidemiol"},{"key":"3096_CR79","doi-asserted-by":"publisher","first-page":"n1380","DOI":"10.1136\/bmj.n1380","volume":"374","author":"A Prete","year":"2021","unstructured":"Prete A, Bancos I. Glucocorticoid induced adrenal insufficiency. BMJ. 2021;374:n1380. https:\/\/doi.org\/10.1136\/bmj.n1380.","journal-title":"BMJ"},{"key":"3096_CR80","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1177\/0897190014546836","volume":"27","author":"KA Wargo","year":"2014","unstructured":"Wargo KA, Edwards JD. Aminoglycoside-induced nephrotoxicity. J Pharm Pract. 2014;27:573\u20137. https:\/\/doi.org\/10.1177\/0897190014546836.","journal-title":"J Pharm Pract"},{"key":"3096_CR81","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/jamia\/ocw042","volume":"24","author":"BA Goldstein","year":"2017","unstructured":"Goldstein BA, Navar AM, Pencina MJ, Ioannidis JPA. Opportunities and challenges in developing risk prediction models with electronic health records data: a systematic review. J Am Med Inf Assoc. 2017;24:198\u2013208. https:\/\/doi.org\/10.1093\/jamia\/ocw042.","journal-title":"J Am Med Inf Assoc"},{"key":"3096_CR82","doi-asserted-by":"publisher","first-page":"106649","DOI":"10.1016\/j.compbiomed.2023.106649","volume":"155","author":"E Hossain","year":"2023","unstructured":"Hossain E, Rana R, Higgins N, Soar J, Barua PD, Pisani AR, Turner K. Natural Language processing in electronic health records in relation to healthcare decision-making: A systematic review. Comput Biol Med. 2023;155:106649. https:\/\/doi.org\/10.1016\/j.compbiomed.2023.106649.","journal-title":"Comput Biol Med"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-025-03096-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-025-03096-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-025-03096-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T16:16:04Z","timestamp":1751472964000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-025-03096-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3096"],"URL":"https:\/\/doi.org\/10.1186\/s12911-025-03096-3","relation":{"references":[{"id-type":"doi","id":"10.1002\/phar.2150","asserted-by":"subject"}]},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"15 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"244"}}